ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer (ANCAII)

Sahlgrenska University Hospital

Status: Enrolling

Conditions: Anal Cancer

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT04792892

ANCA II

Details and patient eligibility

About

Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis is good, but some patients will have recurrent or persistent disease after concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop distant metastases that can be treated with good results.

The aim of this study is to identify and describe functional outcome in patients diagnosed with anal cancer. We will study patients from diagnosis, try to identify early toxicity to treatment and then identify long-term morbidity.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Anal squamous carcinoma diagnosed within the last 2 months

Exclusion criteria

-No informed consent

Trial design

600 participants in 1 patient group

Patients with a new diagnosis of anal cancer

Description:

All patients identified at our national tumour board will be offered to participate

Treatment:

Other: Questionnaires